Review of Duchenne Muscular Dystrophy (DMD) for the Pediatricians in the Community

Darras BT , Menache CC Dystrophinopathies. In: Katriji B , ed. Neuromuscular Disorders in Clinical Practice. 1st ed. Newton, MA: Butterworth-Heinemann ; 2002:1028-1048.

Dooley J. , Gordon KE , Dodds L. , MacSween J. Duchenne muscular dystrophy: a 30-year population-based incidence study. Clin Pediatr . (Phila)2010;49:177-179.

Ciafaloni E. , Fox DJ , Pandya S. , et al. Delayed diagnosis in Duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr. 2009;155:380-385.

Bushby K. , Finkel R. , Birnkrant DJ , et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77-93.

Brooke MH , Fenichel GM , Griggs RC , et al: Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve. 1983;6:91-103.

Kemper AR , Wake MA Duchenne muscular dystrophy: issues in expanding newborn screening. Curr Opin Pediatr. 2007;19:700-704.

Stockley TL , Akber S. , Bulgin N. , Ray PN Strategy for comprehensive molecular testing for Duchenne and Becker muscular dystrophies. Genet Test. 2006;10:229-243.

Online Mendelian Inheritance in Man. Muscular dystrophy, Duchenne type; DMD. http://www.ncbi.nlm.nih.gov/omim/310200. Accessed July 13, 2010.

Gillard EF , Chamberlain JS , Murphy EG , et al. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene . Am J Hum Genet. 1989;45:507-520.

Bushby KM Genetic and clinical correlations of Xp21 muscular dystrophy. J Inherit Metab Dis. 1992;15:551-564.

Monaco AP , Bertelson CJ , Liechti-Gallati S. , et al. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988;2:90-95.

Darras BT , Jones HR Diagnosis of pediatric neuromuscular disorders in the era of DNA analysis . Pediatr Neurol. 2000;23:289-300.

Hoogerwaard EM , Bakker E. , Ippel PF , et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet. 1999;353:2116-2119.

Abbs S. Prenatal diagnosis of Duchenne and Becker muscular dystrophy. Prenat Diagn. 1996;16:1187-1198.

Ozawa E. , Yoshida M. , Hagiwara Y. , et al. Dystrophinassociated proteins in muscular dystrophy. Hum Mol Genet. 1990;4:11711-11716.

Morse RP , Rosman NP : Diagnosis of occult muscular dystrophy: importance of the "chance" finding of elevated serum aminotransferase activities. J Pediatr. 1993;122: 254-256.

Manzur AY , Kuntzer T. , Pike M. , Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2008;(1):CD003725.

Moxley RT III , Ashwal S. , Pandya S. , et al. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2005;64:13-20.

Biggar WD , Gingras M. , Fehlings DL , Harris VA , Steele CA Deflazacort treatment of Duchenne muscular dystrophy. J Pediatr . 2001;138:45-50.

Bothwell JE , Gordon KE , Dooley JM , MacSween J. , Cummings EA , Salisbury S. Vertebral fractures in boys with Duchenne muscular dystrophy. Clin Pediatr (Phila ). 2003;42:353-356.

Blankinship MJ , Gregorevic P. , Chamberlain JS Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors. Mol Ther. 2006;13:241-249.

Arnett AL , Chamberlain JR , Chamberlain JS Therapy for neuromuscular disorders. Curr Opin Genet Dev. 2009;19: 290-297.

Gregorevic P. , Schultz BR , Allen JM , et al. Evaluation of vascular delivery methodologies to enhance rAAV6mediated gene transfer to canine striated musculature. Mol Ther. 2009;17:1427-1433.

Yokota T. , Duddy W. , Partridge T. Optimizing exon skipping therapies for DMD. Acta Myol. 2007;26:179-184. 25. Nelson SF , Crosbie RH , Miceli MC , Spencer MJ Emerging genetic therapies to treat Duchenne muscular dystrophy. Curr Opin Neurol. 2009;22:532-538.

Rosner B. , Prineas RJ , Loggie JM , Daniels SR Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States. J Pediatr. 1993 ;123: 871-886.

Cyrulnik SE , Fee RJ , De Vivo DC , Goldstein E. , Hinton VJ Delayed developmental language milestones in children with Duchenne’s muscular dystrophy. J Pediatr . 2007;150:474-478.

American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics. 2005;116:1569-1573.

Finder JD , Birnkrant D. , Carl J. , et al. Respiratory care of the patient with Duchenne muscular dystrophy: an official ATS consensus statement. Am J Respir Crit Care Med. 2004;170:456-465.

Bushby K. , Finkel R. , Birnkrant DJ , et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol . 2010;9:177-189.